Kids younger than 6 years on extended-release stimulants for ADHD may experience higher rates of side effects due to higher plasma exposures.

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Medications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...

Instead, participants said, classifying methylphenidate a schedule 6 drug “ negatively impacts on treatment adherence ”. Our medicines regulator, the South African Health Products Regulatory Authority ...

In addition, searches for Biphentin and ADHD, methylphenidate transdermal system and ADHD, and Metadate CD and ADHD were performed following the final search to corroborate findings (no additional ...

A new generation of long-acting methylphenidate formulations are now available for the treatment of ADHD. This review analyzes 34 comparative studies to help inform clinical decision-making.

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Collegium's new ADHD drugs may allow the company to grow revenues faster and pay off debt faster. Click here to find out why ...